These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28682461)

  • 1. Influence of decision aids on oral anticoagulant prescribing among physicians: a randomised trial.
    Baicus C; Delcea C; Dima A; Oprisan E; Jurcut C; Dan GA
    Eur J Clin Invest; 2017 Sep; 47(9):649-658. PubMed ID: 28682461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.
    Kaiser K; Cheng WY; Jensen S; Clayman ML; Thappa A; Schwiep F; Chawla A; Goldberger JJ; Col N; Schein J
    Curr Med Res Opin; 2015 Dec; 31(12):2261-72. PubMed ID: 26390360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.
    McGrath ER; Go AS; Chang Y; Borowsky LH; Fang MC; Reynolds K; Singer DE
    J Am Geriatr Soc; 2017 Feb; 65(2):241-248. PubMed ID: 28039855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Translation of Knowledge Into Practice in the Management of Atrial Fibrillation in Singapore.
    Woo BFY; Lim TW; Tam WWS
    Heart Lung Circ; 2019 Apr; 28(4):605-614. PubMed ID: 29705388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation-a qualitative study.
    Aarnio E; Huupponen R; Hämeen-Anttila K; Merikoski M; Puhakka J; Korhonen MJ
    Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):416-422. PubMed ID: 30304573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicians' views and experiences of prescribing oral anticoagulants for stroke prevention in atrial fibrillation: A qualitative meta-synthesis.
    Pritchett RV; Clarke JL; Jolly K; Clarkesmith D; Bem D; Turner GM; Thomas GN; Lane DA
    PLoS One; 2020; 15(5):e0232484. PubMed ID: 32379847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family Physician Prescribing Practices and Perspectives on Shared Decision-Making Regarding the Use of Oral Anticoagulants for Stroke Prevention in Patients 75 Years or Older With Atrial Fibrillation.
    Ali J; Abbasi-Dezfouly R; Khera S; Kivi P; Tian PGJ
    J Prim Care Community Health; 2023; 14():21501319231164060. PubMed ID: 36960556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of decision support system implementation for prescribing anticoagulants to patients with atrial fibrillation in hospital].
    Chernov AA; Kleymenova EB; Sychev DA; Yashina LP; Nigmatkulova MD; Otdelenov VA; Payushchik SA
    Ter Arkh; 2020 Sep; 92(8):37-42. PubMed ID: 33346460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring patient-provider decision-making for use of anticoagulation for stroke prevention in atrial fibrillation: Results of the INFORM-AF study.
    Pokorney SD; Bloom D; Granger CB; Thomas KL; Al-Khatib SM; Roettig ML; Anderson J; Heflin MT; Granger BB
    Eur J Cardiovasc Nurs; 2019 Apr; 18(4):280-288. PubMed ID: 30418049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HRS/NSA 2014 survey of atrial fibrillation and stroke: Gaps in knowledge and perspective, opportunities for improvement.
    Frankel DS; Parker SE; Rosenfeld LE; Gorelick PB
    Heart Rhythm; 2015 Aug; 12(8):e105-13. PubMed ID: 25981149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation.
    Franchi C; Antoniazzi S; Proietti M; Nobili A; Mannucci PM;
    Br J Clin Pharmacol; 2018 Sep; 84(9):2010-2019. PubMed ID: 29745441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review.
    Pritchett RV; Bem D; Turner GM; Thomas GN; Clarke JL; Fellows R; Lane DA; Jolly K
    Thromb Haemost; 2019 Feb; 119(2):294-307. PubMed ID: 30669165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Restraints to anticoagulation prescription in atrial fibrillation and attitude towards the new oral anticoagulants].
    Pereira-Da-Silva T; Souto Moura T; Azevedo L; Sá Pereira M; Virella D; Alves M; Borges L
    Acta Med Port; 2013; 26(2):127-32. PubMed ID: 23809744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
    Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
    Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing primary care physicians' prescribing behavior of anticoagulant therapy for the management of patients with non-valvular atrial fibrillation in Singapore: a qualitative research study.
    Chaterji S; Lian LG; Lee TY; Chua L; Wee SY; Yap SL; K DL; Tan NC
    BMC Fam Pract; 2021 May; 22(1):101. PubMed ID: 34034648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF).
    Vinereanu D; Al-Khalidi HR; Rao MP; He W; Lopes RD; Bahit CM; Ciobanu AO; Fox KA; Pokorney SD; Xian Y; Jiang J; Kamath DY; Berwanger O; Tajer C; Huo Y; Xavier D; Granger CB
    Am Heart J; 2017 Oct; 192():38-47. PubMed ID: 28938962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anticoagulation choices of internal medicine residents for stroke prevention in non-valvular atrial fibrillation.
    Moulson N; McIntyre WF; Oqab Z; Yazdan-Ashoori P; Quinn KL; van Oosten E; Hopman WM; Baranchuk A
    Postgrad Med J; 2017 Jun; 93(1100):308-312. PubMed ID: 27307471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing Stroke Prevention in Patients With Atrial Fibrillation: A Cluster-Randomized Controlled Trial of a Computerized Antithrombotic Risk Assessment Tool in Australian General Practice, 2012-2013.
    Bajorek BV; Magin PJ; Hilmer SN; Krass I
    Prev Chronic Dis; 2016 Jul; 13():E90. PubMed ID: 27418212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation.
    Hsu JC; Chan PS; Tang F; Maddox TM; Marcus GM
    Am J Med; 2015 Jun; 128(6):654.e1-654.e10. PubMed ID: 25554371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.